Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
J Synchrotron Radiat ; 28(Pt 6): 1758-1768, 2021 Nov 01.
Article in English | MEDLINE | ID: mdl-34738929

ABSTRACT

A new correction algorithm for closed orbit distortion based on an adaptive feedforward control (AFC) has been developed. At SPring-8, two helicity-switching twin-helical undulators (THUs) had been implemented with conventional feedforward corrections. However, the validity of these corrections turned out to be expiring due to unforeseen variation in the error magnetic fields with time. The developed AFC system has been applied to the THUs dynamically updating the feedforward table without stopping the helicity switching amid user experiments. The error sources in the two THUs are successfully resolved and corrected even while the two THUs are switching simultaneously with the same repetition period. The actual operation of the new AFC system enables us to keep the orbit variations suppressed with an accuracy at the sub-micrometre level in a transparent way for light source users.

2.
Rev Sci Instrum ; 89(6): 064704, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29960536

ABSTRACT

Since an X-ray Free Electron Laser (XFEL) facility is a linac-based single-user machine, a multi-beamline mode of operation, which improves the efficiency of user experiments, is critical for accommodating users' rapidly increasing demand for beamtime. A key supporting technology is a highly stable pulsed power supply (PS), which enables stable XFEL operations by precisely switching the beam route. We developed a high-power pulsed PS to drive a kicker magnet installed in a SACLA's beam switching system. SiC MOSFETs were adapted as switching elements to reduce the required size and to increase the electric power efficiency. The PS we developed provides two key capabilities: (i) a high current stability of 20 ppm (peak-to-peak) at a peak power of 0.24 MW and (ii) generation of controllable, bipolar, and trapezoidal current waveforms at 60 Hz. This paper describes the overall concept, the detailed design, the performance achieved, and the initial beam test results.

3.
J Nutr Sci Vitaminol (Tokyo) ; 62(2): 81-7, 2016.
Article in English | MEDLINE | ID: mdl-27264091

ABSTRACT

Biotin is a water-soluble vitamin that functions as a cofactor for biotin-dependent carboxylases. The biochemical and physiological roles of biotin in brain regions have not yet been investigated sufficiently in vivo. Thus, in order to clarify the function of biotin in the brain, we herein examined biotin contents, biotinylated protein expression (e.g. holocarboxylases), and biotin-related gene expression in the brain of biotin-deficient rats. Three-week-old male Wistar rats were divided into a control group, biotin-deficient group, and pair-fed group. Rats were fed experimental diets from 3 wk old for 8 wk, and the cortex, hippocampus, striatum, hypothalamus, and cerebellum were then collected. In the biotin-deficient group, the maintenance of total biotin and holocarboxylases, increases in the bound form of biotin and biotinidase activity, and the expression of an unknown biotinylated protein were observed in the cortex. In other regions, total and free biotin contents decreased, holocarboxylase expression was maintained, and bound biotin and biotinidase activity remained unchanged. Biotin-related gene (pyruvate carboxylase, sodium-dependent multivitamin transporter, holocarboxylase synthetase, and biotinidase) expression in the cortex and hippocampus also remained unchanged among the dietary groups. These results suggest that biotin may be related to cortex functions by binding protein, and the effects of a biotin deficiency and the importance of biotin differ among the different brain regions.


Subject(s)
Biotin/deficiency , Brain/metabolism , Animals , Biotinidase/genetics , Biotinidase/metabolism , Carbon-Nitrogen Ligases/genetics , Carbon-Nitrogen Ligases/metabolism , Gene Expression Regulation , Male , Pyruvate Carboxylase/genetics , Pyruvate Carboxylase/metabolism , Rats , Rats, Wistar , Symporters/genetics , Symporters/metabolism
4.
Congenit Anom (Kyoto) ; 50(1): 21-8, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20201965

ABSTRACT

To clarify the role of biotin in palatal formation, we investigated the effects of biotin deficiency on the development of palatal processes in mouse fetuses at midgestation. We also investigated protein expressions in the palatal processes. Pregnant mice were given either a biotin-deficient diet or a biotin-supplemented (control) diet from day 0 of gestation (dg 0). Some dams in the biotin-deficient group were changed to a biotin-supplemented diet on dg 12, 13 or 14. On dg 15, the palatal processes were dissected from these fetuses and their peptides were characterized using two-dimensional electrophoresis and liquid chromatography/tandem mass spectrometry (LC-MS/MS) system. Regarding Trasler's stage for the growth of the palatal processes in mouse fetuses on dg 15, the average stage of palatal development was 5.83 +/- 0.39 in the biotin-supplemented group, 5.39 +/- 0.66 in the dg 13-supplemented group, and 4.64 +/- 0.90 in the biotin-deficient group. The development of the palatal processes significantly increased in relation to the earlier day of biotin supplementation. In a protein analysis of palatal processes by isoelectro focusing (IEF) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), a 19-kDa spot was confirmed around position at pI 6-7 in the biotin-supplemented group, but this protein was not present in either the biotin-deficient group or the dg 13-supplemented group. From the MS/MS database of peptides, adenosine diphosphate (ADP)-ribosylation factor 2 (arf2) and alpha-crystallin were detected in the mesenchyme of the palatal processes. It is suggested that the expression of these proteins may be downregulated by biotin deficiency, inducing the inhibited development of palatal processes.


Subject(s)
Biotin/deficiency , Palate/embryology , Palate/metabolism , ADP-Ribosylation Factors/metabolism , Animals , Cleft Palate/embryology , Electrophoresis, Polyacrylamide Gel , Female , Fetus/drug effects , Gene Expression Regulation, Developmental , Mice , Mice, Inbred ICR , Pregnancy , Tandem Mass Spectrometry , alpha-Crystallins/metabolism
5.
J Nutr Sci Vitaminol (Tokyo) ; 56(5): 279-86, 2010.
Article in English | MEDLINE | ID: mdl-21228497

ABSTRACT

The present study estimated the dietary intake of seven B vitamins using a total diet study (TDS) in Japan. The daily intake of vitamins estimated by TDS was calculated based on the mean contents of vitamins in 18 food groups, and the amount of food intake in the Nation Health and Nutrition Survey in Japan, 2006. The estimated daily intake of these vitamins for all ages was 22.8 mg NE/d for niacin, 7.4 µg/d for vitamin B(12), 146 µg/d for folic acid, 4.52 mg/d for pantothenic acid, 1.06 mg/d for riboflavin, and 1.44 mg/d for pyridoxine. The estimated daily intake of the vitamins of niacin, vitamin B(12) and pyridoxine exceeded the dietary reference values for adults aged 18-29 y. The estimated daily intake of these vitamins by TDS was higher than the daily intake reported in the National Health and Nutrition Survey in Japan, 2006. There was a strongly positive correlation between the intake levels estimated by TDS and those reported in the National Health and Nutrition Survey. This suggests that TDS is an effective dietary survey for estimating the dietary intake of water-soluble vitamins. Therefore, when being determined by TDS, the estimated daily intake of biotin was 51.0 µg/d for all ages.


Subject(s)
Diet , Nutrition Surveys , Nutritional Requirements , Vitamin B Complex/administration & dosage , Adolescent , Adult , Aged , Asian People , Biotin/administration & dosage , Child , Child, Preschool , Folic Acid/administration & dosage , Humans , Infant , Japan , Middle Aged , Niacin/administration & dosage , Nutrition Policy , Pantothenic Acid/administration & dosage , Pyridoxine/administration & dosage , Riboflavin/administration & dosage , Vitamin B 12/administration & dosage , Young Adult
6.
Rinsho Byori ; 57(5): 467-70, 2009 May.
Article in Japanese | MEDLINE | ID: mdl-19522254

ABSTRACT

In 2006, the Ministry of Health and Welfare revised the regulations regarding the Medical Service Law. The amendments stipulate that all healthcare institutions are required to implement infection control programs. However, small hospitals and clinics have no clinical microbiology laboratories, whereas medium-sized hospitals have few medical technologists and the outsourcing of microbiology tests to independent laboratories is common. The decreasing number of laboratories and recent outsourcing tendency reflect the increasing commercialization, and, with it, the escalating number of commercially operating chains. Each independent laboratory is responsible for supporting activities related to the surveillance, control, and prevention of healthcare-associated infections in the associated small and medium-sized hospitals. The people responsible for infection control in these hospitals usually do not have a background in microbiology. The evaluation of communication between independent laboratory staff and hospital personnel, and rapid turnaround time of microbiology laboratory test reports are important elements ensuring the quality of independent laboratory work. With the pressures of financial constraints in the Japanese medical insurance system, the development of a cost-effective and practical protocol for quality assurance is a real dilemma.


Subject(s)
Cross Infection/prevention & control , Infection Control , Laboratories , Microbiology , Outsourced Services , Cost-Benefit Analysis , Hospital Bed Capacity , Hospitals , Humans , Infection Control/methods , Information Services , Japan , Quality Assurance, Health Care/economics
7.
Nutrition ; 25(1): 78-84, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18752930

ABSTRACT

OBJECTIVE: The purpose of this investigation was to determine the effects of biotin deficiency on maternal metabolism and embryonic development in pregnant mouse dams. METHODS: The pregnant mice were randomly assigned to one of three dietary groups and given a biotin-deficient diet, biotin-supplemented diet, or biotin-control diet during gestation. On days of gestation (dgs) 0, 4, 8, 12, and 16, organic acids including 3-hydroxyisovaleric acid in urine were discovered by high-performance liquid chromatography, and the biotin level in the serum and urine was determined by a bioassay. On dg 18, fetuses were examined for morphologic development. RESULTS: In the biotin-deficient group, biotin excretion in urine decreased on dg 4 and was subsequently below the lower limit, whereas the urinary concentration of 3-hydroxyisovaleric acid increased after dg 12. In contrast, the biotin concentration in urine significantly increased on dgs 4, 8 and 12 in the biotin-supplemented group, but decreased on dg 16 in the biotin-supplemented and biotin-control groups. The urinary excretion of pyruvic acid in the biotin-deficient group was significantly higher than that in the biotin-supplemented group throughout the entire gestation. These concentrations in urine significantly increased on dg 16 compared with dg 0. The inhibition of embryonic development and external malformations such as cleft palate (100%), micrognathia (100%), and micromelia (91.4%) were also detected in biotin-deficient fetuses. CONCLUSION: These findings indicated that, as the requirement of biotin increases during gestation and/or embryonic development, a large amount of biotin is necessary for maintaining normal reproductive performance during the late stage of gestation.


Subject(s)
Biotin/deficiency , Biotin/metabolism , Congenital Abnormalities/etiology , Embryonic Development , Energy Metabolism/physiology , Pregnancy, Animal/metabolism , Animals , Biotin/blood , Biotin/urine , Chromatography, High Pressure Liquid/methods , Congenital Abnormalities/epidemiology , Embryonic Development/drug effects , Female , Fetus/metabolism , Gestational Age , Male , Mice , Mice, Inbred ICR , Nutritional Requirements , Pregnancy , Pregnancy Outcome , Random Allocation , Valerates/urine
8.
J Nutr ; 138(4): 680-4, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18356320

ABSTRACT

It has recently been demonstrated that pregnancy in women may cause mild biotin deficiency without any clinical signs. However, the teratogenicity of biotin deficiency in humans has not been well investigated. On the other hand, our previous studies have shown that maternal biotin deficiency induces many kinds of malformations, such as cleft palate, micrognathia, and micromelia, in all animal fetuses. However the mechanism for cleft palate induction under biotin-deficient conditions is unknown. Therefore, to investigate the possible mechanisms for cleft palate induction in embryos, we investigated the effects of biotin deficiency on human embryonic palatal mesenchymal (HEPM) cells in culture in this study. HEPM cells were cultured in biotin-deficient and biotin-physiological (control) media for 5 wk. The proliferative availabilities of HEPM cells in the biotin-deficient state were significantly lower after wk 2 of culture (41.3% of the control). Biotin concentrations in biotin-deficient cells were drastically lower after wk 1 of culture, whereas those in the control cells remained at almost the same level. Biotinidase activities were also lower in biotin-deficient cells. Holocarboxylases in biotin-deficient cells were fewer after the first week of culture and were almost undetectable after wk 2. The amount of biotinylated histones in the nuclei of biotin-deficient cells was lower than in the control cells. This suppressed proliferation of mesenchymal cells may delay or inhibit the growth of palatal processes in embryos and thus it may partially contribute to the mechanisms for cleft palate induction.


Subject(s)
Biotin/deficiency , Biotin/pharmacology , Mesoderm/cytology , Palate/cytology , Palate/embryology , Biotinidase/metabolism , Biotinylation , Cell Proliferation/drug effects , Cells, Cultured , Histones/metabolism , Humans , Vitamins/pharmacology
9.
Biol Pharm Bull ; 31(3): 507-10, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18310919

ABSTRACT

Biotin-binding IgG (B-IgG) in human sera was quantified using previously developed F(ab')(2)anti-human IgG-coated multiwell microplates (Muratsugu M. et al., 2003, Biol. Pharm. Bull., 26, 1605--1608). The levels of B-IgG in sera, however, were higher than those we predicted. In this study, we modified the assay using F(ab')2anti-human IgG-coated multiwell microplates and successfully quantified the levels of B-IgG in sera. The cause of the unpredicted results was discussed in the text. In addition, the levels of biotin-binding IgA (B-IgA) and IgM (B-IgM) in sera could be measured using F(ab')2anti-human IgA- or IgM-coated multiwell microplates. We quantified B-IgG, B-IgA, and B-IgM in sera from healthy specimens and patients with bronchial asthma, atopic dermatitis, epilepsy, and juvenile rheumatoid arthritis.


Subject(s)
Carrier Proteins/blood , Immunoglobulin A/blood , Immunoglobulin Fab Fragments , Immunoglobulin G/blood , Immunoglobulin M/blood , Receptors, Immunologic/immunology , Biotinylation , Carrier Proteins/immunology , Humans , Immunoassay/methods , Immunoglobulin Fab Fragments/immunology , Reference Standards
10.
Biol Pharm Bull ; 29(7): 1480-2, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16819193

ABSTRACT

Biotin-binding IgG in human sera was quantitated using F(ab')(2)anti-human IgG-coated multiwell microplates (Muratsugu, M. et al. 2003, Biol. Pharm. Bull., 26, 1605-1608). The biotin-protein ratio of biotinylated IgG, which was used as standard in the assay, was very important to quantitate the level of biotin-binding IgG. We investigated a synthesis method of biotinylated human immunoglobulins, how to determine the biotin-protein ratio of the biotinylated proteins, and their stability to prepare standards for measuring biotin-binding IgG, IgA, and IgM.


Subject(s)
Biotin/pharmacokinetics , Immunoglobulins/chemistry , Biotinylation , Humans , Immunoglobulin A/metabolism , Immunoglobulin G/metabolism , Immunoglobulin M/metabolism , Protein Binding , Serum Albumin, Bovine/metabolism
11.
J Dermatol ; 32(4): 256-61, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15863846

ABSTRACT

Biotin deficiency is rarely encountered in an infant on weaning from breast and formula feeding. It is characterized by alopecia and scaly, erythematous dermatitis distributed around the body orifices. We report a 5-month-old Japanese infant with typical skin lesions who had been diagnosed as a neonate with dyspepsia and fed only an amino acid formula. Serum and urine levels of biotin were below the normal range, but zinc and biotinidase were within normal range. Urinary excretion of 3-methylcrotonylglycine, 3-hydroxyisovaleric acid, and methylcitric acid was significantly elevated. Daily oral supplementation with 1 mg of biotin resulted in dramatic improvement of the periorificial dermatitis and hair growth together with a complete disappearance of the organic aciduria. Our case shows that the characteristic skin manifestations are the most important clue to the diagnosis of biotin deficiency and demonstrated that urinary excretion of biotin and organic aciduria, rather than the serum concentration of biotin, are the sensitive indicators for evaluating the patient's status of biotin deficiency.


Subject(s)
Biotin/deficiency , Deficiency Diseases/diagnosis , Erythema/diagnosis , Facial Dermatoses/diagnosis , Infant Formula , Biotin/administration & dosage , Biotin/blood , Biotin/urine , Deficiency Diseases/drug therapy , Deficiency Diseases/pathology , Dietary Supplements , Erythema/drug therapy , Erythema/pathology , Facial Dermatoses/drug therapy , Facial Dermatoses/pathology , Humans , Infant , Male , Peritoneum
12.
J Nutr ; 135(3): 615-8, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15735103

ABSTRACT

We developed an assay for measuring urinary 3-hydroxyisovaleric acid (3-HIA) using HPLC after derivatization with 2-nitrophenylhydrazine hydrochloride (2-NPH . HCl). The derivatized 3-HIA was extracted into n-hexane and separated isocratically on a C8 reversed-phase column for fatty acids (YMC-Pack FA). We used this method to measure 3-HIA in urine extracts from mice fed a biotin-deficient diet for >4 wk and in an infant who was fed a special Japanese formula and was suspected of being biotin deficient. Urinary 3-HIA could be assayed within the range of 0.42-8.5 mmol/L with high accuracy by this method, as an indicator of biotin deficiency. Therefore, the HPLC method for 3-HIA described here may be a useful tool clinically as well as in the research laboratory.


Subject(s)
Biotin/deficiency , Biotin/urine , Valerates/urine , Animals , Biomarkers/blood , Chromatography, High Pressure Liquid , Deficiency Diseases/urine , Humans , Infant , Male , Mice , Mice, Inbred ICR , Regression Analysis
13.
J Electron Microsc (Tokyo) ; 53(5): 505-9, 2004.
Article in English | MEDLINE | ID: mdl-15582956

ABSTRACT

Crack-tip dislocations in silicon crystals have been examined by using high-voltage electron microscopy. Cracks were introduced by the Vickers indentation method at room temperature and the indented specimens were annealed at high temperatures to induce dislocations around crack tips under the presence of residual stress due to the indentation. A selected area around a crack tip was thinned by a focused ion beam (FIB) technique. Specimens were thinned in advance by a twin-blade cutting (TBC) method, which is a simple cutting process for saving FIB machine time. A combination of FIB and TBC can be a useful thinning procedure for the efficient preparation of transmission electron microscopy specimens. Characteristic dislocation structures were observed around the tip of a crack, aiding the elucidation of dislocation processes, which is essential to increase the fracture toughness of materials.


Subject(s)
Microscopy, Electron, Transmission , Silicon , Specimen Handling/methods , Crystallization , Equipment Failure Analysis
14.
Biol Pharm Bull ; 27(10): 1666-9, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15467216

ABSTRACT

Beta-dolabrin, gamma-thujaplicin, and 4-acetyltropolone, the components of Aomori Hiba (Thujopsis dolabrata SIEB. et ZUCC. var. hondai MAKINO), showed antifungal activity on seven kinds of plant-pathogenic fungi, antibacterial activity against two kinds of Legionella sp., and in vitro cytotoxic effect on murine P388 lymphocytic leukemia cell line. Firstly, beta-dolabrin, gamma-thujaplicin and 4-acetyltropolone had clear antifungal activity against seven kinds of plant-pathogenic fungi tested. In particular, beta-dolabrin and 4-acetyltropolone showed strong antifungal activity against Pythium aphanidermatum IFO 32440, with minimum inhibitory concentration (MIC) values of 6.0 microg/ml. Secondly, beta-dolabrin, gamma-thujaplicin and 4-acetyltropolone had obvious growth-inhibitory effect on two kinds of Legionella sp. 4-Acetyltropolone especially had strong antibacterial activity toward Legionella pneumophila SG 1, and its MIC value was 3.1 microg/ml. These three compounds showed cytotoxic effects against murine P388 lymphocytic leukemia cell line in vitro. The cytotoxic effect of three compounds in the murine P388 lymphocytic leukemia cell line were clear when cell growth was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. At 48 h after treatment, gamma-thujaplicin and 4-acetyltropolone at 0.63 microg/ml inhibited cell growth of murine P388 lymphocytic leukemia by 85% and 65%, respectively. At the same time after treatment, the growth of the murine P388 lymphocytic leukemia cell line was completely suppressed by the three compounds at concentrations higher than 5.0 microg/ml. Among these three compounds, gamma-thujaplicin had the strongest cytotoxic activity on the growth of this tumor cell line in vitro.


Subject(s)
Cycloheptanes/pharmacology , Monoterpenes/chemistry , Monoterpenes/pharmacology , Tropolone/analogs & derivatives , Tropolone/chemistry , Tropolone/pharmacology , Animals , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Cell Death/drug effects , Cell Line, Tumor , Cycloheptanes/isolation & purification , Fungi/drug effects , Fungicides, Industrial/isolation & purification , Fungicides, Industrial/pharmacology , Legionella/drug effects , Mice , Microbial Sensitivity Tests , Monoterpenes/isolation & purification , Plants/microbiology , Thuja , Tropolone/isolation & purification
15.
Biol Pharm Bull ; 27(6): 899-902, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15187442

ABSTRACT

alpha-Thujaplicin, a minor component of Aomori Hiba (Thujopsis dolabrata SIEB. et ZUCC. var. hondai MAKINO), showed rather strong antifungal activity against seven kinds of plant-pathogenic fungi, their minimum inhibitory concentrations (MICs) being in the range of 12.0-50.0 microg/ml. alpha-Thujaplicin and hinokitiol (the major component of Aomori Hiba) also showed clear antibacterial activity against Legionella pneumophila SG 1 and L. pneumophila SG 3, and their MICs are in the range of 6.25-50 microg/ml. This compound showed strong insecticidal activity against Reticulitermes speratus [50%-lethal concentration (LC(50)): 0.02 g/m(2)], and it also had clear acaricidal activity against Dermatophagoides farinae (LC(50): 0.66 g/m(2)). At 24 h after treatment, alpha-thujaplicin at 0.63 microg/ml inhibited the cell growth of murine P388 lymphocytic leukemia by 78%, and its cytotoxic activity at a concentration higher than 0.63 microg/ml was as high as that of vincristine, used as a positive control. On the other hand, the cytotoxic effect of alpha-thujaplicin at 0.63 microg/ml was weaker than that of vinblastine. In this respect, the strong cytotoxic effect of alpha-thujaplicin on murine P388 lymphocytic leukemia cell line should be emphasized, considering that it has recently been found to be low in toxicity to mice.


Subject(s)
Monoterpenes/pharmacology , Tropolone/analogs & derivatives , Tropolone/pharmacology , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Leukemia P388 , Mice , Monoterpenes/chemistry , Stereoisomerism , Tropolone/chemistry
17.
Biol Pharm Bull ; 26(11): 1605-8, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14600410

ABSTRACT

Biotin-binding human immunoglobulin G (B-IgG) was quantitatively measured using an F(ab')2anti-human IgG-coated multi-well microplate for the first time. B-IgG was caught by F(ab')2anti-human IgG and was detected by the following detecting reagents: Peroxidase-labeled streptavidin, avidin and peroxidase-biotin, or avidin-biotinylated peroxidase complex with method A, B, or C, respectively. Commercially available B-IgG was detected by all these three methods. However, method A and B could not detect B-IgG in the human sera used in this study, but we quantitatively measured the B-IgG level using method C. The result is probably due to the fact that the sensitivity of method C was higher than that of methods A or B. Properties of B-IgG detected by method C are discussed in the text.


Subject(s)
Binding Sites, Antibody , Biotin/blood , Immunoglobulin G/blood , Receptors, Immunologic/blood , Dose-Response Relationship, Immunologic , Humans , Protein Binding/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...